Inhibition of the Fibrinogen‐Like Protein 2:Fc<i>γ</i><scp>RIIB</scp>/<scp>RIII</scp> immunosuppressive pathway enhances antiviral T‐cell and B‐cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13

Olga Luft, Ramzi Khattar, Kaveh Farrokhi, Dario Ferri, Yavorska Nataliya, Jianhua Zhang, Hassan Sadozai, Oyedele Adeyi, Andrzej Chruscinski, Gary Levy,

Immunology · 2018 · 16 citations · 58 references

DOIFull text

Open access

Concepts

Abstract

Summary Persistent viruses evade immune detection by interfering with virus‐specific innate and adaptive antiviral immune responses. Fibrinogen‐like protein‐2 ( FGL 2) is a potent effector molecule of CD 4 + CD 25 + FoxP3 + regulatory T cells and exerts its immunosuppressive activity following ligation to its cognate receptor, Fc γ RIIB / RIII . The role of FGL 2 in the pathogenesis of chronic viral infection caused by lymphocytic choriomeningitis virus clone‐13 ( LCMV cl‐13) was assessed in this study. Chronically infected fgl2 +/+ mice had increased plasma levels of FGL 2, with reduced expression of the maturation markers, CD 80, CD 86 and MHC ‐ II on macrophages and dendritic cells and impaired production of neutralizing antibody. In contrast, fgl2 −/− mice or fgl2 +/+ mice that had been pre‐treated with antibodies to FGL 2 and Fc γ RIIB / RIII and then infected with LCMV cl‐13 developed a robust CD 4 + and CD 8 + antiviral T‐cell response, produced high titred neutralizing antibody to LCMV and cleared LCMV . Treatment of mice with established chronic infection with antibodies to FGL 2 and Fc γ RIIB / RIII was shown to rescue the number and functionality of virus‐specific CD 4 + and CD 8 + T cells with reduced total and virus‐specific T‐cell expression of programmed cell death protein 1 leading to viral clearance. These results demonstrate an important role for FGL 2 in viral immune evasion and provide a rationale to target FGL 2 to treat patients with chronic viral infection.

References

58